Start-Up Previews, May 2014
Executive Summary
This Month's Profile Group, Medtech Start-Ups Innovate In Minimally Invasive Gynecology, features profiles of Channel Medsystems, EmboMedics, and Minerva Surgical. Plus these Start-Ups Across Health Care: Ginolis, Peptineo, Silk Road Medical, and Somersault Orthopedics.
You may also be interested in...
Medtech Start-Ups Innovate In Minimally Invasive Gynecology
Medtech start-ups are taking on the global endometrial ablation and uterine artery embolization markets with next-generation systems designed to raise the standard of care in menorrhagia treatment. Profiles of Channel Medsystems, EmboMedics, and Minerva Surgical.
Minerva Surgical Inc.
Hologic’s NovaSure system has been able to maintain a substantial lead in the US global endometrial ablation market, but Minerva Surgical Inc. is looking to change all that with its effective, easy-to-use RF argon plasma energy-based Minerva Endometrial Ablation System. What makes this competitive scenario especially intriguing is that three of Minerva's founders and eight of its board members were also closely aligned with Novacept, which developed NovaSure.
EmboMedics Inc.
EmboMedics Inc. has developed a bioresorbable embolic bead technology to treat uterine fibroids without causing long-term side effects. Currently in preclinical testing, EmboMedics' technology will initially be used in the treatment of uterine fibroids, although its potential for controlled and predictable drug release could lend itself to a variety of other acute and chronic indications, including liver and prostate cancer, trauma, and obesity.